Microbio Co

Microbio Co P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Microbio Co (4128.TWO) as of Nov 17, 2026 is 665.93. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was 21.83 — a change of 2,950.30% (higher).

P/FCF

665.93

YoY

2,950.30%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Microbio Co is 2025 665.93 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Microbio Co was 2024 21.83 . It decreases by 2,950.30% higher compared to the previous year.

The Microbio Co P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2018
-38.08 TWD
Jan 1, 2019
-48.59 TWD
Jan 1, 2020
356.52 TWD
Jan 1, 2021
-213.88 TWD
Jan 1, 2022
108.59 TWD
Jan 1, 2023
-84.72 TWD
Jan 1, 2024
21.83 TWD
Jan 1, 2025
665.93 TWD
The Microbio Co P/FCF history
YEARP/FCFYoY
665.93+2,950.30%
21.83-125.77%
-84.72-178.01%
108.59-150.77%
-213.88-159.99%
356.52-833.69%
-48.59+27.60%
-38.08-85.91%
-270.30+470.36%
-47.39+40.33%
-33.77+15.30%
-29.29—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Microbio Co Stock analysis

What does Microbio Co do? Microbio Co., Ltd. generates revenue through the sale of fermentation products like Tien Chun Bao (TCB) oral solutions, herbal products such as the LeeHerb series, and organic foods including vegetables, fruits, nuts, pastry, seasonings, and organic meals. The company also sells new medicines, including anticancer drugs, hepatitis treatments, allergy medications, and rheumatoid arthritis therapies. Domestic market sales form the primary distribution channel for all product lines. The firm targets consumers seeking natural health solutions through its Tien Chun Bao and LeeHerb product lines, while healthcare professionals and patients requiring specialized treatments purchase its new medicines. Organic food buyers include health-conscious individuals and households looking for sustainable dietary options. All products are sold within Taiwan's domestic market, with no international distribution mentioned. Microbio Co., Ltd. focuses on three core product segments: fermentation-based health solutions, herbal healthcare products, and organic food items. The anticancer and hepatitis medicine segments serve medical professionals and patients in Taiwan, while allergy and rheumatoid arthritis treatments target specific patient groups. The company's product portfolio is fully contained within Taiwan's domestic market, with no indication of international expansion. Microbio Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Microbio Co stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Microbio Co is 665.93 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Microbio Co changed from 21.83 to 665.93, representing a 2,950.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Microbio Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Microbio Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Microbio Co

All Key Metrics — Microbio Co